Cargando…

Patient attitudes and preferences about expanded noninvasive prenatal testing

Introduction: Noninvasive prenatal testing (NIPT) using cell-free DNA (cfDNA) is typically carried out to screen for common fetal chromosomal anomalies, with the option to screen for a wider range of chromosomal changes (expanded NIPT) becoming increasingly available. However, little is known about...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubois, Marie-Line, Winters, Patricia D., Rodrigue, Marc-André, Gekas, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161390/
https://www.ncbi.nlm.nih.gov/pubmed/37152999
http://dx.doi.org/10.3389/fgene.2023.976051
_version_ 1785037485232881664
author Dubois, Marie-Line
Winters, Patricia D.
Rodrigue, Marc-André
Gekas, Jean
author_facet Dubois, Marie-Line
Winters, Patricia D.
Rodrigue, Marc-André
Gekas, Jean
author_sort Dubois, Marie-Line
collection PubMed
description Introduction: Noninvasive prenatal testing (NIPT) using cell-free DNA (cfDNA) is typically carried out to screen for common fetal chromosomal anomalies, with the option to screen for a wider range of chromosomal changes (expanded NIPT) becoming increasingly available. However, little is known about pregnant patients’ attitudes and preferences regarding expanded NIPT. Methods: To address this gap, we surveyed general-risk patients having first-tier cfDNA screening at a private prenatal clinic on their expectations for expanded NIPT. Patients were asked questions regarding their current pregnancy and previous pregnancy history, their opinions on fetal DNA screenings during pregnancy and incidental findings, information and opinions on financial resources for NIPT, as well as socio-cultural questions to determine patient demographics. Results: Of the 200 survey participants, the majority were educated, self-reported as white, had a higher than average income, and reported no aneuploidy risk factors. When asked what information they would like to receive from cfDNA screening, the vast majority of participants wanted all information available that could have an immediate impact on fetal health (88%) or an immediate impact on infant health from birth (82%). Many participants also wanted information that could have a future impact on the child’s health or an immediate or future impact on the pregnant woman’s own health. Most participants wanted information about the sex of fetus (86%) and common trisomies (71%), with almost half of participants desiring information about rare autosomal aneuploidies and/or all genetic information that may affect the baby. In addition, participants were found to be comfortable screening for conditions that are well-known, influence care during pregnancy, and are treatable. Finally, while most respondents either had insurance coverage for NIPT or were able to afford NIPT out of pocket, the majority of our participants felt that expanded NIPT should be either free for everyone or for those considered high risk. Discussion: Our findings suggest that with appropriate pre-test counseling, pregnant patients may choose NIPT for an expanding list of conditions.
format Online
Article
Text
id pubmed-10161390
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101613902023-05-06 Patient attitudes and preferences about expanded noninvasive prenatal testing Dubois, Marie-Line Winters, Patricia D. Rodrigue, Marc-André Gekas, Jean Front Genet Genetics Introduction: Noninvasive prenatal testing (NIPT) using cell-free DNA (cfDNA) is typically carried out to screen for common fetal chromosomal anomalies, with the option to screen for a wider range of chromosomal changes (expanded NIPT) becoming increasingly available. However, little is known about pregnant patients’ attitudes and preferences regarding expanded NIPT. Methods: To address this gap, we surveyed general-risk patients having first-tier cfDNA screening at a private prenatal clinic on their expectations for expanded NIPT. Patients were asked questions regarding their current pregnancy and previous pregnancy history, their opinions on fetal DNA screenings during pregnancy and incidental findings, information and opinions on financial resources for NIPT, as well as socio-cultural questions to determine patient demographics. Results: Of the 200 survey participants, the majority were educated, self-reported as white, had a higher than average income, and reported no aneuploidy risk factors. When asked what information they would like to receive from cfDNA screening, the vast majority of participants wanted all information available that could have an immediate impact on fetal health (88%) or an immediate impact on infant health from birth (82%). Many participants also wanted information that could have a future impact on the child’s health or an immediate or future impact on the pregnant woman’s own health. Most participants wanted information about the sex of fetus (86%) and common trisomies (71%), with almost half of participants desiring information about rare autosomal aneuploidies and/or all genetic information that may affect the baby. In addition, participants were found to be comfortable screening for conditions that are well-known, influence care during pregnancy, and are treatable. Finally, while most respondents either had insurance coverage for NIPT or were able to afford NIPT out of pocket, the majority of our participants felt that expanded NIPT should be either free for everyone or for those considered high risk. Discussion: Our findings suggest that with appropriate pre-test counseling, pregnant patients may choose NIPT for an expanding list of conditions. Frontiers Media S.A. 2023-04-18 /pmc/articles/PMC10161390/ /pubmed/37152999 http://dx.doi.org/10.3389/fgene.2023.976051 Text en Copyright © 2023 Dubois, Winters, Rodrigue and Gekas. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Dubois, Marie-Line
Winters, Patricia D.
Rodrigue, Marc-André
Gekas, Jean
Patient attitudes and preferences about expanded noninvasive prenatal testing
title Patient attitudes and preferences about expanded noninvasive prenatal testing
title_full Patient attitudes and preferences about expanded noninvasive prenatal testing
title_fullStr Patient attitudes and preferences about expanded noninvasive prenatal testing
title_full_unstemmed Patient attitudes and preferences about expanded noninvasive prenatal testing
title_short Patient attitudes and preferences about expanded noninvasive prenatal testing
title_sort patient attitudes and preferences about expanded noninvasive prenatal testing
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161390/
https://www.ncbi.nlm.nih.gov/pubmed/37152999
http://dx.doi.org/10.3389/fgene.2023.976051
work_keys_str_mv AT duboismarieline patientattitudesandpreferencesaboutexpandednoninvasiveprenataltesting
AT winterspatriciad patientattitudesandpreferencesaboutexpandednoninvasiveprenataltesting
AT rodriguemarcandre patientattitudesandpreferencesaboutexpandednoninvasiveprenataltesting
AT gekasjean patientattitudesandpreferencesaboutexpandednoninvasiveprenataltesting